Home / News / CMS advises Oaktree on sale of Kadans Science Par...

CMS advises Oaktree on sale of Kadans Science Partner

CMS has advised Oaktree Capital Management on the Dutch aspects of the sale of Kadans Science Partner to AXA Investment Managers.

Kadans, a property investor and developer, owns and operates science parks and lab offices throughout the Netherlands, the UK and Germany. Kadans focuses on the European Life Sciences sector and seeks to increase its portfolio in Europe.

AXA is a long term investor with significant financial resources and intends to use its extensive European network to help Kadans grow across Europe. Kadans’s existing management team retains a minority stake in Kadans.

CMS Team
The CMS team consisted of Roman Tarlavski, Lisanne van der Velden, Robert Jong, Jenny Noordermeer, Giulia Wientjens and Jan Peter IJspeert.

Related people

Picture of Roman Tarlavsky
Roman Tarlavski
Partner
Amsterdam
Picture of Lisanne van der Velden
Lisanne van der Velden
Advocaat
Amsterdam
Robert-Jong-18-Edit-CMS-NL
Robert Jong
Advocaat
Amsterdam
Giulia-Wientjens
Giulia Wientjens
Advocaat
Amsterdam
Picture of Jan Peter IJspeert
Jan Peter IJspeert
Counsel
Amsterdam
Jenny Noordermeer
Show more Show less